Translational Adult Glioma Grant

Overview

Mission

The mission of the Ben and Catherine Ivy Foundation is to improve the quality of life and increase the life expectancy of people diagnosed with brain tumors. We fund promising research on brain cancer in order to develop diagnostics and treatments that lead to long-term survival and a high quality of life for these patients.

Values

The Ben and Catherine Ivy Foundation holds a strong set of values that clearly guides all funding decisions in order to fulfill our mission of helping patients with brain tumors.

* Innovation
* We believe that creative and open-minded thinking will contribute to finding a cure for brain tumors.
* Efficiency
* We support the effective use of resources with an emphasis on avoiding duplication.
* Transparency
* We consider the open sharing of all research results, not only “successes,” as the best way to advance the field.
* Accountability
* We expect detailed communication about the use of funds and believe that research can demonstrate progress through careful and hands-on monitoring of measurable goals.
* Excellence
* We seek out projects that are exceptionally developed with the purpose of serving patients and advancing brain cancer treatment.

* Collaboration
* We reach across disciplines and institutions as a way of including many different and varied perspectives and increasing synergistic efforts.
* Integrity
* We uphold the highest standards and expect our grant recipients to do the same.
* Flexibility
* We look for ways to respond quickly and to utilize information as an opportunity to learn.

Ivy Foundation Translational Adult Glioma Grant Award

The Ben & Catherine Ivy Foundation Emerging Adult Glioma Award provides grant support to investigators conducting high-impact, high-reward translational research for glioblastoma.  This award is intended to support projects designed to contribute to identifying therapies that will impact the survival of patients with brain cancer.

Award Terms

* $600,000 total, payments received at initiation and completion of project
* Project duration is 24 months
* The proposal milestones are to be completed within the two year award timeline
* Indirect costs not to exceed 10% (included in award total-$60,000 maximum)
* One Principal Investigator allowed; Co-Investigators permitted (only one position allowed per year)
* No Cost Extensions are not permitted by contract

Eligibility

_You can learn more about this opportunity by visiting the funder's website._

* Eligibility
* A PhD, MD or equivalent is required.
* Only one submission per applicant is permitted every calendar year, as PI and or CO Investigator.
* Applicants need not be U.S. citizens, but must be employed by a U.S. non-profit academic institution.
* The Ben & Catherine Ivy Foundation does not discriminate on the basis of race, color, religion, national origin, sex, gender identity, sexual orientation, age, disability or any other legally protected characteristics.
* Clinical trials eligible
* Applicants must have a faculty appointment as an independent investigator.

Ineligibility

* Travel expenses excluded.
* BioTech companies are ineligible.